SI Materials and Methods

Strains and oligonucleotides
All strains and sequences of all synthetic DNA oligonucleotides (oligos) are listed in Supplementary Dataset S3. PCR primers were obtained from Integrated DNA Technologies with standard desalting. High-Throughput (HT) sequencing primers were purified with highperformance liquid chromatography (HPLC).
DIvERGE oligonucleotides
DIvERGE oligos were designed to have minimized secondary structure (>-12 kcal/mol) and targeted the replicating lagging strand. For the targeted mutagenesis of the landing pad, two sets of DNA oligos (TETRM1, TETRM3) with equimolar spiking levels of 0, 0.1, 0.5, 2, 5, 10, and 20% were synthesized. For targeted mutagenesis of folA, DIvERGE oligos were designed to cover the entire locus in E. coli K-12 MG1655, E. coli CFT073, and Salmonella enterica subsp. serovar Typhimurium str. LT2 in which mutations have been previously observed to confer trimethoprim resistance (Supplementary Dataset S2). In order to mutagenize gyrA in E.
coli K-12, DIvERGE oligos were designed to cover the entire protein-coding sequence and the corresponding upstream promoter sequence. In vivo ssDNA processing results in the removal of the 9 terminal mismatching nucleobases during the course of integration and subsequent DNA repair, therefore an overlap of 9 nucleobases in both directions ensured that all targeted genomic positions had an equally high probability of mutagenesis.
Synthesis of the spiked DIvERGE and reference oligos was performed on an ABI3900
DNA synthesizer (Applied Biosystems), according to a modified phosphoramidite chemistry- 
DIvERGE cycling process
DIvERGE in E. coli K-12 MG1655, E. coli UPEC CFT073, Salmonella enterica LT2, and
Citrobacter freundii ATCC 8090 was performed based on the previously described pORTMAGE3 (Addgene plasmid #72678)) protocol(1) with the corresponding spiked oligos (see Supplementary Dataset S3). Briefly, cells were subjected to pORTMAGE cycles in 10 ml culture volumes of Lysogeny-Broth-Lennox (LB L ) media (10 g of tryptone, 5 g of yeast extract, 5 g of sodium chloride per 1 L of water) with 50 g/ml kanamycin. 40 l of the electrocompetent cell suspension was mixed with the DIvERGE oligos at a 2.5 M final concentration.
Electroporation was done on a BTX (Harvard Apparatus) CM-630 Exponential Decay Wave
Electroporation System in 1 mm gap electroporation cuvettes (1.8 kV, 200 , 25 F).
Immediately after electroporation, cells were suspended in 5 ml TB media (24 g yeast extract, 12 g tryptone, 9.4 g K2HPO4, and 2 g KH2PO4 per 1 L of water) to allow for cells to recover.
The cells could later be transferred to larger volumes for further growth and cycling.
Multiplex iterative DIvERGE cycles were carried out to mutagenize either folA or gyrA by equimolarly mixing each set of spiked oligos, covering the entire target region. 4 l of these oligo mixtures were electroporated into competent cells which were then suspended in 5 ml fresh TB media to allow for recovery at 30°C for 1 hour under continuous agitation. An extra 5 ml LB L media was then added along with kanamycin to maintain pORTMAGE3. At this point, cells were either subjected to additional pORTMAGE cycles by growing to mid-log phase and preparing electrocompetent cells again or allowed to reach stationary phase and aliquoted into 1 ml portions to which 0.5 ml 50% glycerol was added. The aliquoted samples were then frozen and stored at -80°C for subsequent phenotypic or genotypic analysis.
A single round of multiplex DIvERGE cycle was carried out to simultaneously mutagenize gyrA, gyrB, parE and parC by equimolarly mixing 130 individual DIvERGE oligos.
Separately, 4 l of these oligo mixtures were electroporated into E. coli K-12 MG1655 cells in 10 parallel replicates and the resulting cell libraries were combined in 50 ml fresh TB media.
Following recovery, cells were diluted by the addition of 50 ml LB L media and allowed to reach stationary phase at 30°C under continuous agitation. Aliquoted samples were then frozen and stored at -80°C. Library generation experiments were performed in triplicates.
To assess the single step mutational landscape of folA, scanning DIvERGE was carried out by introducing each of the 8 folA-targeting oligos separately in triplicates. Following the addition of 1 ml TB recovery media, 300 l of each of the individual populations were combined for all replicates, separately and supplemented with additional TB for a final volume of 5 ml.
These combined populations were then allowed to recover for 1 hour at 30°C, after which 5 ml LB media was added. The combined populations were then grown to stationary phase overnight at 30°C. Aliquots were then prepared and stored in the aforementioned manner. This approach permits the mutational scanning of the entire folA, with every nucleotide position mutant statistically present in the population after only 1 cycle.
In order to measure the integration dynamics in different species of oligos spiked at various levels, TETRM1 and TETRM3 oligos spiked at all positions at 0.1%, 0.5%, 1%, 2%, 5%, 10% and 20% levels were targeted to the landing pad sequence integrated in the genomes of E. coli K-12 MG1655, S. enterica LT2, and C. freundii ATCC 8090. A total of 5 consecutive DIvERGE cycles were carried out with all different spiked oligos. After the final cycles, populations were frozen and stored in the manner described above. From the aliquoted frozen populations recovered after each DIvERGE cycle, genomic DNA was extracted from ~2 × 10 9 cells using GenElute™ Bacterial Genomic DNA kit (Sigma-Aldrich).
Determination of mutation frequencies
To determine mutation frequencies in E. coli K-12 MG1655 at the targeted folA and at the untargeted rpoB loci, the 5-cycle DIvERGE populations were assessed for resistance to trimethoprim and rifampicin, respectively. For this assay, a wild-type E. coli K-12 MG1655
starter culture was grown overnight at 30°C in LB L and diluted 1000-fold into 12 parallel samples in 1 ml LB L media. Cultures were grown overnight at 30°C. As a next step, 1 ml samples were harvested from the overnight grown cultures and from a 5-cycle folA- Highly trimethoprim-resistant variants were selected on agar plates containing 1000 g/ml trimethoprim. Individual resistant clones were then isolated for further genotype-and trimethoprim susceptibility-analysis and all colonies, numbering from 800 to 1000 per sample for SMRT or 1000 to 3000 per sample for Illumina HT sequencing, were scraped off from plates in 5 ml MS media, from which 0.5 ml was used to extract genomic DNA (using GeneElute Bacterial Genomic DNA Kit, Sigma). 190 bp average fragment length). Fragments were purified with AMPure XP and eluted in water; subsequent end repair was performed, dA tailing and ligation steps were unaltered.
GyrA
Library preparation and sequencing were done using a MiSeq Reagent Kit v2 for a 250 bp paired-end (PE) sequencing run on a MiSeq (Illumina).
Nucleotide composition analysis in Landing Pad libraries and DIvERGE oligo pools
Illumina MiSeq sequencing reads were analyzed with an in-house pipeline to increase accuracy and reduce sequencing noise in DIvERGE library analysis. To remove sequencing read-ends that have higher error probability, paired-end Illumina reads were first trimmed to 190 nucleotides and were subsequently imported to CLC Genomics Workbench Tool (CLC Bio, Version 9.0) for pre-processing. Quality trim with an error threshold of 0.001 (Phred Q value of 30) was then applied to remove any erroneous sequence region and overlapping read pairs were then merged. Two different alignment strategies were applied depending on the source of the sequencing library. When assessing TETRM Landing Pad regions after consecutive DIvERGE cycles, alignments were carried out using CLC Genomics Workbench.
To compare the mutational spectrum and mutation frequency on DIvERGE oligos and at the corresponding genomic targets, the BWA-MEM algorithm(2) (version 0.7.5a-r405) was called with default parameters. To increase fidelity, supplementary alignments and soft trim regions were removed from the binary alignments with SAMtools(3) (version: 0.1.19-96b5f2294a) and NGSUtils(4) (version 0.5.7-e98ddfa), respectively. JVarkit(5) was then applied to select reads that exactly spanned the entire target TETRM target region. Blastn (version 2.2.28+(6)) was finally used to report the number of alterations between mapped reads and their target regions.
In order to assess mutation frequencies and yield a nucleotide composition table for For each strain, 6 sequencing libraries were analyzed, 3 replicates in which only the regulatory region was targeted for each, and 3 replicates in which only the protein-coding region of folA was targeted with DIvERGE mutagenesis. Strict read-quality control ensured that only high quality (an error probability threshold 0.001 was applied (Phred value = 30)) reads were applied in the downstream analysis.
Mutation summary on the amino acid level for the protein-coding and mutation summary on the DNA level for the regulatory region was carried out as described in SI Materials and Methods. When assessing the single-step DNA level mutational landscape of folA, only reads that displayed exactly one DNA mismatch compared to the reference sequence were used to determine mismatch counts and mismatch abundance for each mapping positions. These reads were mapped to the corresponding (E. coli K-12 MG1655 (NCBI Reference Sequence: 
Isolation of individual genotypes
Defined genotypes were either isolated directly from DIvERGE libraries or were reconstructed individually within the parental strains using pORTMAGE3 recombineering(1). To reconstruct genotypes, ssDNA oligonucleotides, carrying the mutation of interest, were designed to target the replicating lagging-strand of gyrA, parC, and folA. Mutants were generated by performing pORTMAGE genome editing according to a previously described pORTMAGE protocol(1).
Clones were then isolated and the presence of the corresponding mutations was confirmed by colony-PCR and subsequent capillary-sequencing. Oligonucleotides for mutant reconstructions and allele confirmations are listed in Supplementary Dataset S3.
Fitness measurements
Growth rate measurements to assess the fitness effect of DIvERGE were performed by growing replicates of E. coli K-12 MG1655 wild-type (n = 6) and randomly chosen, DIvERGE generated (n = 30) individual, trimethoprim-resistant isolates in LB L medium. Cultures of the studied mutants were incubated at 30 °C until early stationary phase, followed by the transfer of ~10 3 cells from each into 96-well shallow plates containing 100 l LB L medium. Separately, the growth rate of the newly identified GyrA Gly288Asp mutant was compared to the clinicallyoccurring mutants of GyrA, Ser83Leu and Ser83Leu + Asp87Asn. Growth rate measurements of E. coli K-12 MG1655 GyrA Gly288Asp, Ser83Leu, and Ser83Leu + Asp87Asn were performed in cation-adjusted Mueller Hinton II Broth (Sigma-Aldrich) at 37 °C for each strain (n = 24). Growth curves were recorded by measuring OD600 every 7 min for 24 h at 30°C using a Biotek Powerwave XS2 automated plate reader. The growth rate was calculated from the obtained growth curves following a previously reported procedure(9, 10). Two-tailed t-tests were conducted for each strains compared to the wild-type E. coli K-12 MG1655.
Antibiotic resistance measurements
Minimum inhibitory concentrations (MIC) of trimethoprim for E. coli K-12 MG1655, E. coli
CFT073, and Salmonella enterica LT2 were quantified with E-test strips (bioMerieux) on MS + casamino acid (without thiamine) agar plates. E-test MIC determinations were carried out in
accordance with the manufacturer's instructions.
Trimethoprim susceptibility was determined in MS media + casamino acid (without thiamine). Trimethoprim resistance, quantified as the 75% inhibitory concentration of trimethoprim (IC75), was calculated from the function of growth versus trimethoprim concentrations. Specifically, the IC75 value was calculated as the trimethoprim concentration at which the area under the growth curve of the given cell population was equal to one-quarter of an uninhibited control. As a measure of the effect of each individual genotype, relative IC75 values for each of the corresponding mutants were determined and compared to the IC75 of the wild-type. Measurements were performed in triplicates.
Ciprofloxacin and gepotidacin MICs of the wild-type and the corresponding mutant strains were compared by a standard microdilution method in 96-well shallow plates (11, 12) . 
A
Escherichia coli K-12 MG1655
Position Reference nucleotide Detected mutation -58 
A Position
Reference allele Detected SNPs COUNTS -100 (14) . The sequencing data for the landing pad assay-based DIvERGE mutagenesis was obtained from strains that had undergone five cycles.
Using pORTMAGE (see Methods), we estimate that there were 10 cell-generations per each DIvERGE cycle (Supplementary Table S6 ). Based on the basal mutation rate of wild-type E.
coli K-12 MG1655. 5 cycles of DIvERGE mutagenesis (50 generations) would yield 1.1*10 -8 mutations per nucleotide as the basal background mutation rate. As for Salmonella enterica LT2 and Citrobacter freundii ATCC 8090, whole-genome sequencing based mutation rate measurement data is not available. Therefore, to assess the estimated background mutation rate in DIvERGE mutagenesis, we calculated the basal mutation rate based on the available mutation rate measurements from rifampicin-resistance fluctuation analysis for these species.
Step
Time-frame Number of cell generations
Growth to mid-log phase (to reach OD600 = 0.4-0.6) 
